SOX2 and ductal breast carcinoma in situ: To further explore these findings in breast cancer, we performed correlations between SOX2 expression levels and lymphonodal status and explored expression of SOX2 in metastatic lymph nodes as well as in earlier disease stages such as ductal carcinoma in situ.